MBOT

Dopo l'orario di chiusura: .92 -0.0201 -2.14%

Microbot Medical Inc (MBOT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Microbot Medical Inc Stock (MBOT) Company Profile

Microbot Medical Inc

Healthcare (1182)

908-938-5561

25 RECREATION PARK DR SUITE 108, HINGHAM, MA

@microbotmedical

Prossima data di guadagno

Ultimi documenti SEC

MBOT's Discussions on Twitter

Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2020-01-13	Reiterato	H.C. Wainwright	Buy
2019-12-24	Reiterato	H.C. Wainwright	Buy
2018-01-31	Iniziato	Ladenburg Thalmann	Buy

Microbot Medical Inc Borsa (MBOT) Ultime notizie

Microbot Medical Inc Azioni (MBOT) Dati Finanziari

Microbot Medical Inc (MBOT)

Microbot Medical Inc Stock (MBOT) Company Profile

Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades

Microbot Medical Inc Borsa (MBOT) Ultime notizie

Microbot Medical Releases Investor Presentation Materials - TipRanks

Yoav Zvi Waizer Net Worth (2024) - GuruFocus.com

Microbot Medical LIBERTY System Trial Advancing Faster Than Expected - MPO-mag

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025 - MSN

Microbot Medical Stock Rises After Completing ACCESS-PVI Trial - Yahoo Finance

Market Update: Microbot Medical Inc (MBOT) Sees Positive Movement, Closing at 0.96 - The Dwinnex

Microbot Medical completes key clinical trial, eyes FDA submission By Investing.com - Investing.com Australia

Microbot eyes FDA application for surgical robot after completing pivotal trial - Medical Device Network

Microbot Medical completes enrolment for ACCESS-PVI clinical trial - Vascular News

Microbot Medical completes key clinical trial, eyes FDA submission - Investing.com

Microbot Medical Advances Towards FDA Submission and Market Entry - TipRanks

Microbot Medical Announces the Successful Completion of its - GlobeNewswire

Microbot Medical faces Nasdaq delisting over share price - Investing.com India

Microbot Medical faces Nasdaq delisting over share price By Investing.com - Investing.com South Africa

Microbot Medical nears end of pivotal clinical trial - Investing.com

Microbot shifts pivotal trial up a gear with completion expected ahead of schedule - Medical Device Network

Microbot Medical Nears FDA Submission with Clinical Advances - TipRanks

Microbot Medical Inc. Accelerates Patient Enrollment of Its Pivotal Human Clinical Trial - Marketscreener.com

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to - The Bakersfield Californian

Microbot Medical Accelerates Patient Enrollment of its - GlobeNewswire

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up - StockTitan

Epoch Investment Partners Inc. Decreases Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat

MicroAlgo receives Nasdaq minimum bid price warning - Investing.com

MicroAlgo Faces Nasdaq Minimum Price Warning - TipRanks

MLGO’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Quarterly Snapshot: Quick and Current Ratios for MicroAlgo Inc (MLGO) - The Dwinnex

The Wild Robot giveaway - Lyles Movie Files

Pedro Pascal and Lupita Nyong’o starrer The Wild Robot to release in Indian theatres on October 18 - Bollywood Hungama

Win Advance Screening Passes to THE WILD ROBOT in Florida - FlickDirect, Your Premiere Source For Movies And Entertainment!

Creo Medical Partners with Micro-Tech for Strategic Growth - TipRanks

Microbot Medical (NASDAQ:MBOT) & Treace Medical Concepts (NASDAQ:TMCI) Head-To-Head Review - Defense World

OrbiMed executives purchase $12 million of MBX Biosciences stock By Investing.com - Investing.com UK

The Wild Robot- Chicago – Advance Screening - The Movie Blog

Microbot Medical Advances in Endovascular Robotic Trials - TipRanks

Microbot Medical Announces the Successful Enrollment of 50% - GlobeNewswire

Microbot Medical Inc. Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System - Marketscreener.com

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System - Yahoo Finance

Microbot Medical Stock Is Moving Higher: What's Going On? - MSN

Microbot Medical Shares Investor Presentation Update - TipRanks

Trial Enrollment For LIBERTY Robotic Surgical System Reaches Midpoint - MPO-mag

MBOT stock touches 52-week low at $0.85 amid market challenges - Investing.com

Market Resilience: Microbot Medical Inc (MBOT) Finishes Weak at 0.88, Down -4.35 - The Dwinnex

THINK Surgical scoops additional FDA 510(k) clearance on Tmini surgical robot - Medical Device Network

Microbot Medical, Emory University To Consider LIBERTY Robotic System Partnership - MPO-mag

Microbot Medical advances Liberty Robotic System telesurgery innovation - Yahoo Finance

Microbot Medical, Emory University to Consider LIBERTY Robotic System Partnership - MPO-mag

Microbot Medical (MBOT) Inks New Phase 2 Agreement for LIBERTY - MSN

Microbot advances Liberty robotic system to next phase of remote telesurgery evaluation - Medical Device Network

Microbot Medical advances telesurgery with new phase - Investing.com India

Microbot Medical advances telesurgery with new phase By Investing.com - Investing.com Canada

Examining MBOT’s book value per share for the latest quarter - US Post News

Microbot Medical Inc Azioni (MBOT) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a MBOT